Trial site
Oncology Hematology Care, Inc
- 19running trials
- 8closed trials
The trials here
What the 27 trials at this site are about, from their registry records.
- Conditions
- Lung cancer5 trials
- Childhood cancers4 trials
- Chronic myeloid leukaemia4 trials
- Chronic lymphocytic leukaemia3 trials
- Ovarian cancer3 trials
- Mantle cell lymphoma2 trials
- Multiple myeloma2 trials
- Myeloproliferative neoplasms2 trials
- Sarcoma2 trials
- Triple-negative breast cancer2 trials
- Acute lymphoblastic leukaemia1 trial
- Acute myeloid leukaemia1 trial
- and 3 more
- Phase
- Phase 315 trials
- Phase 26 trials
- Phase 12 trials
- Phase 42 trials
- Phase 2/31 trial
- Status
- Active, not recruiting10 trials
- Recruiting9 trials
- Completed8 trials
- Lead sponsor
- Eli Lilly and Company4 trials
- Novartis Pharmaceuticals4 trials
- Amgen3 trials
- Loxo Oncology, Inc.3 trials
- Gilead Sciences2 trials
- and 9 more
Running trials
Recruiting
A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
A Phase 2 Study of Tarlatamab in Patients With Small Cell Lung Cancer (SCLC)
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Active, not recruiting
Active, not recruiting
A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung Cancer
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers3 recruiting
- Ovarian cancer2 recruiting
- Acute lymphoblastic leukaemia1 recruiting
- Chronic lymphocytic leukaemia1 recruiting
- Chronic myeloid leukaemia1 recruiting
- Multiple myeloma1 recruiting
- Myeloproliferative neoplasms1 recruiting
- Prostate cancer1 recruiting
- Sarcoma1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026